Wms Partners, LLC Acumen Pharmaceuticals, Inc. Transaction History

Wms Partners, LLC

  • $1.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
SELL
$4.81 - $10.17 $393,299 - $831,570
-81,767 Reduced 45.41%
98,301 $530,000
Q3 2022

Nov 08, 2022
SELL
$4.44 - $10.48 $4,440 - $10,480
-1,000 Reduced 0.55%
180,068 $1.81 Million
Q1 2022

May 10, 2022
BUY
$3.91 - $6.73 $707,975 - $1.22 Million
181,068 New
181,068 $708,000

Others Institutions Holding ABOS

# of Institutions
78
Shares Held
41.8M
Call Options Held
57.7K
Put Options Held
749K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $74.9M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email